UniProt ID | ZN496_HUMAN | |
---|---|---|
UniProt AC | Q96IT1 | |
Protein Name | Zinc finger protein 496 | |
Gene Name | ZNF496 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 587 | |
Subcellular Localization | Nucleus . | |
Protein Description | DNA-binding transcription factor that can both act as an activator and a repressor.. | |
Protein Sequence | MPTALCPRVLAPKESEEPRKMRSPPGENPSPQGELPSPESSRRLFRRFRYQEAAGPREALQRLWDLCGGWLRPERHTKEQILELLVLEQFLAILPREIQSWVRAQEPESGEQAVAAVEALEREPGRPWQWLKHCEDPVVIDDGDSPLDQEQEQLPVEPHSDLAKNQDAQPITLAQCLGLPSRPPSQLSGDPVLQDAFLLQEENVRDTQQVTTLQLPPSRVSPFKDMILCFSEEDWSLLDPAQTGFYGEFIIGEDYGVSMPPNDLAAQPDLSQGEENEPRVPELQDLQGKEVPQVSYLDSPSLQPFQVEERRKREELQVPEFQACPQTVVPQNTYPAGGNPRSLENSLDEEVTIEIVLSSSGDEDSQHGPYCTEELGSPTEKQRSLPASHRSSTEAGGEVQTSKKSYVCPNCGKIFRWRVNFIRHLRSRREQEKPHECSVCGELFSDSEDLDGHLESHEAQKPYRCGACGKSFRLNSHLLSHRRIHLQPDRLQPVEKREQAASEDADKGPKEPLENGKAKLSFQCCECGKAFQRHDHLARHRSHFHLKDKARPFQCRYCVKSFTQNYDLLRHERLHMKRRSKQALNSY | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
13 | Sumoylation | CPRVLAPKESEEPRK CCCCCCCCCCCCCCC | 69.16 | 28112733 | |
13 (in isoform 2) | Ubiquitination | - | 69.16 | - | |
13 | Ubiquitination | CPRVLAPKESEEPRK CCCCCCCCCCCCCCC | 69.16 | - | |
23 | Phosphorylation | EEPRKMRSPPGENPS CCCCCCCCCCCCCCC | 31.76 | 30266825 | |
30 | Phosphorylation | SPPGENPSPQGELPS CCCCCCCCCCCCCCC | 41.24 | 30266825 | |
37 | Phosphorylation | SPQGELPSPESSRRL CCCCCCCCHHHHHHH | 54.66 | 30266825 | |
50 | Phosphorylation | RLFRRFRYQEAAGPR HHHHHHHHHHHHCHH | 14.16 | 30622161 | |
181 | Phosphorylation | AQCLGLPSRPPSQLS HHHHCCCCCCHHHHC | 63.56 | 26074081 | |
185 | Phosphorylation | GLPSRPPSQLSGDPV CCCCCCHHHHCCCCH | 46.57 | 20044836 | |
188 | Phosphorylation | SRPPSQLSGDPVLQD CCCHHHHCCCCHHHH | 33.25 | 28387310 | |
218 | Phosphorylation | TTLQLPPSRVSPFKD EEEECCHHHCCCCCC | 43.29 | 26074081 | |
221 | Phosphorylation | QLPPSRVSPFKDMIL ECCHHHCCCCCCEEE | 24.41 | 30266825 | |
269 | Ubiquitination | NDLAAQPDLSQGEEN HHCCCCCCCCCCCCC | 47.04 | 21963094 | |
289 | Ubiquitination | ELQDLQGKEVPQVSY HHHHHCCCCCCCCEE | 42.45 | 21906983 | |
295 | Phosphorylation | GKEVPQVSYLDSPSL CCCCCCCEECCCCCC | 18.09 | 26074081 | |
296 | Phosphorylation | KEVPQVSYLDSPSLQ CCCCCCEECCCCCCC | 18.70 | 26074081 | |
299 | Phosphorylation | PQVSYLDSPSLQPFQ CCCEECCCCCCCCCC | 17.50 | 28112733 | |
301 | Phosphorylation | VSYLDSPSLQPFQVE CEECCCCCCCCCCHH | 43.52 | 26074081 | |
325 | Ubiquitination | VPEFQACPQTVVPQN CCCCCCCCCCCCCCC | 35.57 | 21963094 | |
325 (in isoform 2) | Ubiquitination | - | 35.57 | - | |
388 | Phosphorylation | KQRSLPASHRSSTEA HHHCCCCCCCCCCCC | 19.93 | 25627689 | |
391 | Phosphorylation | SLPASHRSSTEAGGE CCCCCCCCCCCCCCC | 35.87 | 27251275 | |
392 | Phosphorylation | LPASHRSSTEAGGEV CCCCCCCCCCCCCCE | 30.17 | 25159151 | |
393 | Phosphorylation | PASHRSSTEAGGEVQ CCCCCCCCCCCCCEE | 30.97 | 25627689 | |
403 | Sumoylation | GGEVQTSKKSYVCPN CCCEECCCCCEECCC | 49.48 | 28112733 | |
403 | Sumoylation | GGEVQTSKKSYVCPN CCCEECCCCCEECCC | 49.48 | - | |
404 | Sumoylation | GEVQTSKKSYVCPNC CCEECCCCCEECCCC | 46.95 | - | |
404 | Sumoylation | GEVQTSKKSYVCPNC CCEECCCCCEECCCC | 46.95 | - | |
445 | Phosphorylation | SVCGELFSDSEDLDG CCCHHHCCCCCCCCC | 53.50 | 30576142 | |
447 | Phosphorylation | CGELFSDSEDLDGHL CHHHCCCCCCCCCCH | 31.63 | - | |
496 | Sumoylation | DRLQPVEKREQAASE CCCCCHHHHHHHHHC | 62.56 | 28112733 | |
496 | Sumoylation | DRLQPVEKREQAASE CCCCCHHHHHHHHHC | 62.56 | - | |
519 | Sumoylation | PLENGKAKLSFQCCE CCCCCCEEEEEEECC | 48.42 | - | |
519 | Sumoylation | PLENGKAKLSFQCCE CCCCCCEEEEEEECC | 48.42 | - | |
561 | Phosphorylation | QCRYCVKSFTQNYDL CCHHHHHHHHHCHHH | 17.09 | 26503514 | |
580 | Phosphorylation | RLHMKRRSKQALNSY HHHHHHHHHHHHHCC | 32.90 | 29083192 | |
586 | Phosphorylation | RSKQALNSY------ HHHHHHHCC------ | 32.82 | 29083192 | |
587 | Phosphorylation | SKQALNSY------- HHHHHHCC------- | 22.85 | 29083192 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ZN496_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ZN496_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ZN496_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
NSD1_HUMAN | NSD1 | physical | 15169884 | |
TIF1B_HUMAN | TRIM28 | physical | 20176155 | |
CBX3_HUMAN | CBX3 | physical | 20176155 | |
ZN483_HUMAN | ZNF483 | physical | 25416956 | |
ZSC22_HUMAN | ZSCAN22 | physical | 25416956 | |
ZKSC4_HUMAN | ZKSCAN4 | physical | 25416956 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-299, AND MASSSPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-185, AND MASSSPECTROMETRY. |